Human Brain Cell Transplantation Study Aims To Reverse Nerve And Brain
December 29, 1998
Source: ScienceDaily Magazine
LOS ANGELES -- While growing cells in petri dishes has been done
for more than a century, this old technique is being applied in ground-breaking new ways,
and with space-age equipment, at Cedars-Sinai Medical Center's Neurofunctional Surgery
Center. The goal is to produce cures for such previously incurable conditions as spinal
cord injuries, stroke, epilepsy, and Parkinson's disease. Using molecular biology
technology, scientists have developed specialized neuronal cells ready to be transplanted
for certain neurological conditions.
The project was sparked by the recent discovery of human brain cells' potential for
regeneration, contradicting previous scientific assumptions. "While it is true that
brain cells don't regenerate in situ, we have found that a very small number of brain
cells, harvested and placed into a special environment, can be stimulated to regenerate,
and that regeneration continues when the cells are re-introduced into the brain,"
says neurosurgeon Michel Levesque, M.D., Director of the Neurofunctional Surgery Center at
Cedars-Sinai Medical Center.
Dr. Levesque's partner in the work is Toomas Neuman, Ph.D., Director of Neurobiology at
Cedars-Sinai Medical Center. The two are working to culture a number of carefully targeted
brain cells from a patient, stimulating the cell's growth and regeneration in a regulated
environment. They will then re-introduce the cells into the patient, where the goal is for
growth to continue, effecting healing and repairing damaged brain tissue.
The current plan involves selective cell harvesting and implantation to treat
neurodegenerative diseases such as Parkinson's Disease. An infinitely more complex
protocol for treating stroke and spinal cord injuries is in development.
This protocol will involve identifying, growing and re-introducing a complex mixture of
cells to restore damaged neural circuitry. For example, in treating epilepsy patients who
require surgery, a small piece of the cortex -- where some of the few brain cells capable
of regeneration are located - is removed. The cells are frozen and stored in a cell bank
of neurons until it is time to grow them in petri dishes.
Dr. Levesque is the lead surgeon and growth stimulation is under the direction of Dr.
Neuman. The cells are removed and placed in a special environment to stimulate growth and
division. "The cells don't spontaneously regenerate in the body -- that's why certain
types of brain injuries and illnesses are currently incurable or irreparable," says
Dr. Neuman. "Our eventual goal is to be able to stimulate the cells without removing
them first."
A variety of molecular biology tools is used to identify and stimulate the cells. The
growing cells, which require a sterile, biologically stable environment, are placed in
incubators -- like baby incubators. They are then placed in a special bath that includes
different growth factors. Both the stable environment and the bath containing the growth
factors are required.
Dr. Levesque and Dr. Neuman are collaborating with NeuroGeneration, a new biotechnology
firm in Los Angeles, which is providing the cells. Funding for this research was supported
in part by the Spinal Cord Society.
Note: This story has been adapted from a news release issued by Cedars-Sinai
Medical Center for journalists and other members of the public. If you wish to quote
from any part of this story, please credit Cedars-Sinai Medical Center as the original
source.
|